000300226 001__ 300226
000300226 005__ 20250812155234.0
000300226 0247_ $$2doi$$a10.1038/s41380-025-02990-6
000300226 0247_ $$2pmid$$apmid:40164694
000300226 0247_ $$2ISSN$$a1359-4184
000300226 0247_ $$2ISSN$$a1476-5578
000300226 037__ $$aDKFZ-2025-00688
000300226 041__ $$aEnglish
000300226 082__ $$a610
000300226 1001_ $$aHuang, Zhuxi$$b0
000300226 245__ $$aMutation of CHD7 impairs the output of neuroepithelium transition that is reversed by the inhibition of EZH2.
000300226 260__ $$a[London]$$bSpringer Nature$$c2025
000300226 3367_ $$2DRIVER$$aarticle
000300226 3367_ $$2DataCite$$aOutput Types/Journal article
000300226 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1755006712_26963
000300226 3367_ $$2BibTeX$$aARTICLE
000300226 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000300226 3367_ $$00$$2EndNote$$aJournal Article
000300226 500__ $$aDKFZ-ZMBH Alliance /2025 Sep;30(9):4094-4109
000300226 520__ $$aHaploinsufficiency of CHD7 (Chromo-Helicase-DNA binding protein 7) causes a severe congenital disease CHARGE syndrome. Brain anomaly such as microcephaly and olfactory bulb agenesis seen in CHARGE patients have not been mimicked in previous animal models. Here, we uncover an indispensable function of CHD7 in the neuroepithelium (NE) but not in the neural stem cells (NSCs) after NE transition. Loss of Chd7 in mouse NE resulted in CHARGE-like brain anomalies due to reduced proliferation and differentiation of neural stem and progenitor cells, which were recapitulated in CHD7 KO human forebrain organoids. Mechanistically, we find that CHD7 activates neural transcription factors by removing the repressive histone mark H3K27me3 and promoting chromatin accessibility. Importantly, neurodevelopmental defects caused by CHD7 loss in human brain organoids and mice were ameliorated by the inhibition of H3K27me3 methyltransferase EZH2. Altogether, by implementing appropriate experimental models, we uncover the pathogenesis of CHD7-associated neurodevelopmental diseases, and identify a potential therapeutic opportunity for CHARGE syndrome.
000300226 536__ $$0G:(DE-HGF)POF4-311$$a311 - Zellbiologie und Tumorbiologie (POF4-311)$$cPOF4-311$$fPOF IV$$x0
000300226 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000300226 7001_ $$aHe, Chenxi$$b1
000300226 7001_ $$aWang, Guangfu$$b2
000300226 7001_ $$aZhu, Ming$$b3
000300226 7001_ $$aTong, Xiaoyu$$b4
000300226 7001_ $$aFeng, Yi$$b5
000300226 7001_ $$aZhang, Chenyang$$b6
000300226 7001_ $$aDong, Shuhua$$b7
000300226 7001_ $$0P:(DE-He78)044b8e7cc52bce80fe9afd70f8f4d44e$$aHarim, Yassin$$b8$$udkfz
000300226 7001_ $$0P:(DE-He78)76aeb2431f7458c9261e69c5420390c6$$aLiu, Haikun$$b9$$udkfz
000300226 7001_ $$aZhou, Wenhao$$b10
000300226 7001_ $$00000-0002-8559-7146$$aLan, Fei$$b11
000300226 7001_ $$aFeng, Weijun$$b12
000300226 773__ $$0PERI:(DE-600)1502531-7$$a10.1038/s41380-025-02990-6$$n9$$p4094-4109$$tMolecular psychiatry$$v30$$x1359-4184$$y2025
000300226 909CO $$ooai:inrepo02.dkfz.de:300226$$pVDB
000300226 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)044b8e7cc52bce80fe9afd70f8f4d44e$$aDeutsches Krebsforschungszentrum$$b8$$kDKFZ
000300226 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)76aeb2431f7458c9261e69c5420390c6$$aDeutsches Krebsforschungszentrum$$b9$$kDKFZ
000300226 9131_ $$0G:(DE-HGF)POF4-311$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vZellbiologie und Tumorbiologie$$x0
000300226 9141_ $$y2025
000300226 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2024-12-18$$wger
000300226 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-18
000300226 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-18
000300226 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-18
000300226 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2024-12-18
000300226 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-12-18
000300226 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2024-12-18
000300226 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2024-12-18
000300226 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2024-12-18
000300226 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-18
000300226 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bMOL PSYCHIATR : 2022$$d2024-12-18
000300226 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2024-12-18
000300226 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2024-12-18
000300226 915__ $$0StatID:(DE-HGF)9910$$2StatID$$aIF >= 10$$bMOL PSYCHIATR : 2022$$d2024-12-18
000300226 9201_ $$0I:(DE-He78)A240-20160331$$kA240$$lA240 Molekulare Neurogenetik$$x0
000300226 980__ $$ajournal
000300226 980__ $$aVDB
000300226 980__ $$aI:(DE-He78)A240-20160331
000300226 980__ $$aUNRESTRICTED